Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Overactive Bladder Treatment Companies

Overactive bladder (OAB) is a medical condition characterized by a sudden, involuntary contraction of the muscles in the bladder wall, leading to a frequent and urgent need to urinate. Several pharmaceutical and biotechnology companies focus on the development of treatments for OAB.

Overactive Bladder Treatment Market

Latest Overactive Bladder Treatment Companies Updates:

Astellas Pharma expands indications for Myrbetriq® (mirabegron) to include treatment of overactive bladder (OAB) with urge urinary incontinence (UUI) in men in the US: This approval broadens the reach of this popular medication, benefiting more OAB patients.

Medtronic unveils a new neuromodulation therapy system for OAB, the InterStim™ Micro neurostimulator: This smaller, implantable device offers a less invasive option for patients seeking long-term relief from OAB symptoms.

Urovant Sciences receives FDA approval for Géneresse® (vibegron extended-release tablets) for the treatment of OAB in adults: This new generic drug expands treatment options and potentially contributes to cost reduction for patients.

Botox® continues to dominate the neuromodulation segment: Allergan's botulinum toxin A injections remain a well-established option for OAB treatment, despite increasing competition from newer technologies.

List of Overactive Bladder Treatment Key companies in the market:

Astellas Pharma Inc.

Pfizer Inc.

Teva Pharmaceutical

Allergan Plc.

Mylan N.V.

Endo International Plc

Hisamitsu Pharmaceutical Co. Inc.

Sanofi S. A.

Aurobindo Pharma Limited

Johnson & Johnson"

Overactive Bladder Treatment Market Highlights:

Overactive Bladder Treatment Market Size

Overactive Bladder Treatment Market Trends

Overactive Bladder Treatment Market Analysis

Overactive Bladder Treatment Market Share

Overactive Bladder Treatment Market Highlights:

Overactive Bladder Treatment Market Trends

Overactive Bladder Treatment Market Analysis

Overactive Bladder Treatment Market Share

Overactive Bladder Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.